Tweet by The Lancet on semaglutide

16bf102fc319d621a456d9f821071253_normal.jpeg spacer.png
The Lancet
⁦‪@TheLancet‬⁩
logo_twitter-1497383721365.png
spacer_464x1-1582829598167.png
On the cover, a study assesses the efficacy and safety of semaglutide 50 mg for the treatment of overweight or obesity in adults without type 2 diabetes.

Find this and more in our latest issue: hubs.li/Q020dDSx0 pic.twitter.com/R17m1N2n2r

8/25/23, 8:18 AM

Joseph Thornton

Published by Joseph Thornton MD

Teacher, Clinical Supervisor Clinical Associate Professor, Psychiatry University of Florida Affiliation is for identification only. All content and opinions are my own.

Leave a comment